Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS (xuño de 1995). "Androgen receptor defects: historical, clinical, and molecular perspectives". Endocrine Reviews16 (3): 271–321. PMID7671849. doi:10.1210/edrv-16-3-271.
Gottlieb B, Lombroso R, Beitel LK, Trifiro MA (xaneiro de 2005). "Molecular pathology of the androgen receptor in male (in)fertility". Reproductive Biomedicine Online10 (1): 42–8. PMID15705293. doi:10.1016/S1472-6483(10)60802-4.
Choong CS, Wilson EM (decembro de 1998). "Trinucleotide repeats in the human androgen receptor: a molecular basis for disease". Journal of Molecular Endocrinology21 (3): 235–57. PMID9845666. doi:10.1677/jme.0.0210235.
Meehan KL, Sadar MD (maio de 2003). "Androgens and androgen receptor in prostate and ovarian malignancies". Frontiers in Bioscience8 (1–3): d780–800. PMID12700055. doi:10.2741/1063.
Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL, Wilson EM, McDonnell DP, Cidlowski JA (decembro de 2006). "International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors". Pharmacological Reviews58 (4): 782–97. PMID17132855. doi:10.1124/pr.58.4.9.
Bardin CW, Brown T, Isomaa VV, Jänne OA (1983). "Progestins can mimic, inhibit and potentiate the actions of androgens". Pharmacology & Therapeutics23 (3): 443–59. PMID6371845. doi:10.1016/0163-7258(83)90023-2.
Mooradian AD, Morley JE, Korenman SG (febreiro de 1987). "Biological actions of androgens". Endocrine Reviews8 (1): 1–28. PMID3549275. doi:10.1210/edrv-8-1-1.
Heinlein CA, Chang C (outubro de 2002). "The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions". Molecular Endocrinology16 (10): 2181–7. PMID12351684. doi:10.1210/me.2002-0070.
Davison SL, Bell R (abril de 2006). "Androgen physiology". Seminars in Reproductive Medicine24 (2): 71–7. PMID16633980. doi:10.1055/s-2006-939565.
Frank GR (setembro de 2003). "Role of estrogen and androgen in pubertal skeletal physiology". Medical and Pediatric Oncology41 (3): 217–21. PMID12868122. doi:10.1002/mpo.10340.
Walters KA, Simanainen U, Handelsman DJ (marzo de 2010). "Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models". Human Reproduction Update16 (5): 543–58. PMID20231167. doi:10.1093/humupd/dmq003.
Sinnesael M, Claessens F, Laurent M, Dubois V, Boonen S, Deboel L, Vanderschueren D (decembro de 2012). "Androgen receptor (AR) in osteocytes is important for the maintenance of male skeletal integrity: evidence from targeted AR disruption in mouse osteocytes". Journal of Bone and Mineral Research27 (12): 2535–43. PMID22836391. doi:10.1002/jbmr.1713.
Heemers HV, Tindall DJ (decembro de 2007). "Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex". Endocrine Reviews28 (7): 778–808. PMID17940184. doi:10.1210/er.2007-0019.
Pandini G, Mineo R, Frasca F, Roberts CT, Marcelli M, Vigneri R, Belfiore A (marzo de 2005). "Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells". Cancer Research65 (5): 1849–57. PMID15753383. doi:10.1158/0008-5472.CAN-04-1837.
Vlahopoulos S, Zimmer WE, Jenster G, Belaguli NS, Balk SP, Brinkmann AO, Lanz RB, Zoumpourlis VC, Schwartz RJ (marzo de 2005). "Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic gene". The Journal of Biological Chemistry280 (9): 7786–92. PMID15623502. doi:10.1074/jbc.M413992200.
Fu M, Wang C, Reutens AT, Wang J, Angeletti RH, Siconolfi-Baez L, Ogryzko V, Avantaggiati ML, Pestell RG (xullo de 2000). "p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation". The Journal of Biological Chemistry275 (27): 20853–60. PMID10779504. doi:10.1074/jbc.M000660200.
Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R (marzo de 2006). "Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells". Oncogene25 (14): 2011–21. PMID16434977. doi:10.1038/sj.onc.1209231.
Fu M, Rao M, Wu K, Wang C, Zhang X, Hessien M, Yeung YG, Gioeli D, Weber MJ, Pestell RG (xullo de 2004). "The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity". The Journal of Biological Chemistry279 (28): 29436–49. PMID15123687. doi:10.1074/jbc.M313466200.
Trapman J, Klaassen P, Kuiper GG, van der Korput JA, Faber PW, van Rooij HC, Geurts van Kessel A, Voorhorst MM, Mulder E, Brinkmann AO (maio de 1988). "Cloning, structure and expression of a cDNA encoding the human androgen receptor". Biochemical and Biophysical Research Communications153 (1): 241–8. PMID3377788. doi:10.1016/S0006-291X(88)81214-2.
Rajender S, Singh L, Thangaraj K (marzo de 2007). "Phenotypic heterogeneity of mutations in androgen receptor gene". Asian Journal of Andrology9 (2): 147–79. PMID17334586. doi:10.1111/j.1745-7262.2007.00250.x.
Gregory CW, He B, Wilson EM (decembro de 2001). "The putative androgen receptor-A form results from in vitro proteolysis". Journal of Molecular Endocrinology27 (3): 309–19. PMID11719283. doi:10.1677/jme.0.0270309.
Brinkmann AO, Klaasen P, Kuiper GG, van der Korput JA, Bolt J, de Boer W, Smit A, Faber PW, van Rooij HC, Geurts van Kessel A (1989). "Structure and function of the androgen receptor". Urological Research17 (2): 87–93. PMID2734982. doi:10.1007/BF00262026.
Langley E, Zhou ZX, Wilson EM (decembro de 1995). "Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer". The Journal of Biological Chemistry270 (50): 29983–90. PMID8530400. doi:10.1074/jbc.270.50.29983.
Berrevoets CA, Doesburg P, Steketee K, Trapman J, Brinkmann AO (agosto de 1998). "Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2)". Molecular Endocrinology12 (8): 1172–83. PMID9717843. doi:10.1210/me.12.8.1172.
Dubbink HJ, Hersmus R, Verma CS, van der Korput HA, Berrevoets CA, van Tol J, Ziel-van der Made AC, Brinkmann AO, Pike AC, Trapman J (setembro de 2004). "Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor". Molecular Endocrinology18 (9): 2132–50. PMID15178743. doi:10.1210/me.2003-0375.
Saporita AJ, Zhang Q, Navai N, Dincer Z, Hahn J, Cai X, Wang Z (outubro de 2003). "Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor". The Journal of Biological Chemistry278 (43): 41998–2005. PMID12923188. doi:10.1074/jbc.M302460200.
Heinlein CA, Chang C (abril de 2002). "Androgen receptor (AR) coregulators: an overview". Endocrine Reviews23 (2): 175–200. PMID11943742. doi:10.1210/edrv.23.2.0460.
Ayub M, Levell MJ (agosto de 1989). "The effect of ketoconazole related imidazole drugs and antiandrogens on [3H] R 1881 binding to the prostatic androgen receptor and [3H]5 alpha-dihydrotestosterone and [3H]cortisol binding to plasma proteins". J. Steroid Biochem.33 (2): 251–5. PMID2788775. doi:10.1016/0022-4731(89)90301-4.
Helsen C, Van den Broeck T, Voet A, Prekovic S, Van Poppel H, Joniau S, Claessens F (agosto de 2014). "Androgen receptor antagonists for prostate cancer therapy". Endocrine-Related Cancer21 (4): T105–18. PMID24639562. doi:10.1530/ERC-13-0545.
Knee DA, Froesch BA, Nuber U, Takayama S, Reed JC (abril de 2001). "Structure-function analysis of Bag1 proteins. Effects on androgen receptor transcriptional activity". The Journal of Biological Chemistry276 (16): 12718–24. PMID11278763. doi:10.1074/jbc.M010841200.
Froesch BA, Takayama S, Reed JC (May 1998). "BAG-1L protein enhances androgen receptor function". The Journal of Biological Chemistry273 (19): 11660–6. PMID9565586. doi:10.1074/jbc.273.19.11660.
Song LN, Coghlan M, Gelmann EP (xaneiro de 2004). "Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor". Molecular Endocrinology18 (1): 70–85. PMID14593076. doi:10.1210/me.2003-0189.
Masiello D, Chen SY, Xu Y, Verhoeven MC, Choi E, Hollenberg AN, Balk SP (outubro de 2004). "Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells". Molecular Endocrinology18 (10): 2388–401. PMID15256534. doi:10.1210/me.2003-0436.
Yang F, Li X, Sharma M, Sasaki CY, Longo DL, Lim B, Sun Z (marzo de 2002). "Linking beta-catenin to androgen-signaling pathway". The Journal of Biological Chemistry277 (13): 11336–44. PMID11792709. doi:10.1074/jbc.M111962200.
Amir AL, Barua M, McKnight NC, Cheng S, Yuan X, Balk SP (agosto de 2003). "A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4". The Journal of Biological Chemistry278 (33): 30828–34. PMID12799378. doi:10.1074/jbc.M301208200.
Mulholland DJ, Read JT, Rennie PS, Cox ME, Nelson CC (agosto de 2003). "Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis". Oncogene22 (36): 5602–13. PMID12944908. doi:10.1038/sj.onc.1206802.
Pawlowski JE, Ertel JR, Allen MP, Xu M, Butler C, Wilson EM, Wierman ME (xuño de 2002). "Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells". The Journal of Biological Chemistry277 (23): 20702–10. PMID11916967. doi:10.1074/jbc.M200545200.
Sato N, Sadar MD, Bruchovsky N, Saatcioglu F, Rennie PS, Sato S, Lange PH, Gleave ME (xullo de 1997). "Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP". The Journal of Biological Chemistry272 (28): 17485–94. PMID9211894. doi:10.1074/jbc.272.28.17485.
Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP (abril de 2001). "Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation". The Journal of Biological Chemistry276 (16): 13442–51. PMID11278309. doi:10.1074/jbc.M006598200.
Lee DK, Duan HO, Chang C (marzo de 2001). "Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation". The Journal of Biological Chemistry276 (13): 9978–84. PMID11266437. doi:10.1074/jbc.M002285200.
Beauchemin AM, Gottlieb B, Beitel LK, Elhaji YA, Pinsky L, Trifiro MA (2001). "Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy". Brain Research Bulletin56 (3–4): 285–97. PMID11719263. doi:10.1016/S0361-9230(01)00583-4.
Kim J, Jia L, Stallcup MR, Coetzee GA (febreiro de 2005). "The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus". Journal of Molecular Endocrinology34 (1): 107–18. PMID15691881. doi:10.1677/jme.1.01701.
Frønsdal K, Engedal N, Slagsvold T, Saatcioglu F (novembro de 1998). "CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1". The Journal of Biological Chemistry273 (48): 31853–9. PMID9822653. doi:10.1074/jbc.273.48.31853.
Ishitani K, Yoshida T, Kitagawa H, Ohta H, Nozawa S, Kato S (xullo de 2003). "p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor". Biochemical and Biophysical Research Communications306 (3): 660–5. PMID12810069. doi:10.1016/S0006-291X(03)01021-0.
Reutens AT, Fu M, Wang C, Albanese C, McPhaul MJ, Sun Z, Balk SP, Jänne OA, Palvimo JJ, Pestell RG (maio de 2001). "Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner". Molecular Endocrinology15 (5): 797–811. PMID11328859. doi:10.1210/mend.15.5.0641.
Petre-Draviam CE, Williams EB, Burd CJ, Gladden A, Moghadam H, Meller J, Diehl JA, Knudsen KE (xaneiro de 2005). "A central domain of cyclin D1 mediates nuclear receptor corepressor activity". Oncogene24 (3): 431–44. PMID15558026. doi:10.1038/sj.onc.1208200.
Lee DK, Duan HO, Chang C (marzo de 2000). "From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator". The Journal of Biological Chemistry275 (13): 9308–13. PMID10734072. doi:10.1074/jbc.275.13.9308.
Bonaccorsi L, Muratori M, Carloni V, Marchiani S, Formigli L, Forti G, Baldi E (agosto de 2004). "The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells". Steroids69 (8–9): 549–52. PMID15288768. doi:10.1016/j.steroids.2004.05.011. hdl:2158/395763.
Koshy B, Matilla T, Burright EN, Merry DE, Fischbeck KH, Orr HT, Zoghbi HY (setembro de 1996). "Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase". Human Molecular Genetics5 (9): 1311–8. PMID8872471. doi:10.1093/hmg/5.9.1311.
Rigas AC, Ozanne DM, Neal DE, Robson CN (novembro de 2003). "The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathway". The Journal of Biological Chemistry278 (46): 46087–93. PMID12958311. doi:10.1074/jbc.M306219200.
Wang L, Lin HK, Hu YC, Xie S, Yang L, Chang C (xullo de 2004). "Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells". The Journal of Biological Chemistry279 (31): 32444–52. PMID15178691. doi:10.1074/jbc.M313963200.
Gaughan L, Logan IR, Cook S, Neal DE, Robson CN (xullo de 2002). "Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor". The Journal of Biological Chemistry277 (29): 25904–13. PMID11994312. doi:10.1074/jbc.M203423200.
Veldscholte J, Berrevoets CA, Brinkmann AO, Grootegoed JA, Mulder E (marzo de 1992). "Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation". Biochemistry31 (8): 2393–9. PMID1540595. doi:10.1021/bi00123a026.
Wang Q, Sharma D, Ren Y, Fondell JD (novembro de 2002). "A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression". The Journal of Biological Chemistry277 (45): 42852–8. PMID12218053. doi:10.1074/jbc.M206061200.
Sharma M, Zarnegar M, Li X, Lim B, Sun Z (novembro de 2000). "Androgen receptor interacts with a novel MYST protein, HBO1". The Journal of Biological Chemistry275 (45): 35200–8. PMID10930412. doi:10.1074/jbc.M004838200.
Ueda T, Mawji NR, Bruchovsky N, Sadar MD (outubro de 2002). "Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells". The Journal of Biological Chemistry277 (41): 38087–94. PMID12163482. doi:10.1074/jbc.M203313200.
Wang Q, Udayakumar TS, Vasaitis TS, Brodie AM, Fondell JD (abril de 2004). "Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells". The Journal of Biological Chemistry279 (17): 17319–28. PMID14966121. doi:10.1074/jbc.M400970200.
Tan JA, Hall SH, Petrusz P, French FS (setembro de 2000). "Thyroid receptor activator molecule, TRAM-1, is an androgen receptor coactivator". Endocrinology141 (9): 3440–50. PMID10965917. doi:10.1210/endo.141.9.7680.
He B, Minges JT, Lee LW, Wilson EM (marzo de 2002). "The FXXLF motif mediates androgen receptor-specific interactions with coregulators". The Journal of Biological Chemistry277 (12): 10226–35. PMID11779876. doi:10.1074/jbc.M111975200.
Alen P, Claessens F, Schoenmakers E, Swinnen JV, Verhoeven G, Rombauts W, Peeters B (xaneiro de 1999). "Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform". Molecular Endocrinology13 (1): 117–28. PMID9892017. doi:10.1210/mend.13.1.0214.
Zhou ZX, He B, Hall SH, Wilson EM, French FS (febreiro de 2002). "Domain interactions between coregulator ARA(70) and the androgen receptor (AR)". Molecular Endocrinology16 (2): 287–300. PMID11818501. doi:10.1210/mend.16.2.0765.
Gao T, Brantley K, Bolu E, McPhaul MJ (outubro de 1999). "RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays". Molecular Endocrinology13 (10): 1645–56. PMID10517667. doi:10.1210/mend.13.10.0352.
Goo YH, Na SY, Zhang H, Xu J, Hong S, Cheong J, Lee SK, Lee JW (febreiro de 2004). "Interactions between activating signal cointegrator-2 and the tumor suppressor retinoblastoma in androgen receptor transactivation". The Journal of Biological Chemistry279 (8): 7131–5. PMID14645241. doi:10.1074/jbc.M312563200.
Liao G, Chen LY, Zhang A, Godavarthy A, Xia F, Ghosh JC, Li H, Chen JD (febreiro de 2003). "Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT". The Journal of Biological Chemistry278 (7): 5052–61. PMID12441355. doi:10.1074/jbc.M206374200.
Dotzlaw H, Moehren U, Mink S, Cato AC, Iñiguez Lluhí JA, Baniahmad A (abril de 2002). "The amino terminus of the human AR is target for corepressor action and antihormone agonism". Molecular Endocrinology16 (4): 661–73. PMID11923464. doi:10.1210/me.16.4.661.
Fu M, Wang C, Reutens AT, Wang J, Angeletti RH, Siconolfi-Baez L, et al. (xullo 2000). "p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation". The Journal of Biological Chemistry275 (27): 20853–60. PMID10779504. doi:10.1074/jbc.M000660200.
Zhang Y, Fondell JD, Wang Q, Xia X, Cheng A, Lu ML, Hamburger AW (agosto de 2002). "Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1". Oncogene21 (36): 5609–18. PMID12165860. doi:10.1038/sj.onc.1205638.
Yang F, Li X, Sharma M, Zarnegar M, Lim B, Sun Z (maio de 2001). "Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6". The Journal of Biological Chemistry276 (18): 15345–53. PMID11278661. doi:10.1074/jbc.M010311200.
Lee SR, Ramos SM, Ko A, Masiello D, Swanson KD, Lu ML, Balk SP (xaneiro de 2002). "AR and ER interaction with a p21-activated kinase (PAK6)". Molecular Endocrinology16 (1): 85–99. PMID11773441. doi:10.1210/mend.16.1.0753.
Pero R, Lembo F, Palmieri EA, Vitiello C, Fedele M, Fusco A, Bruni CB, Chiariotti L (febreiro de 2002). "PATZ attenuates the RNF4-mediated enhancement of androgen receptor-dependent transcription". The Journal of Biological Chemistry277 (5): 3280–5. PMID11719514. doi:10.1074/jbc.M109491200.
Kotaja N, Aittomäki S, Silvennoinen O, Palvimo JJ, Jänne OA (decembro de 2000). "ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation". Molecular Endocrinology14 (12): 1986–2000. PMID11117529. doi:10.1210/mend.14.12.0569.
Moilanen AM, Karvonen U, Poukka H, Yan W, Toppari J, Jänne OA, Palvimo JJ (febreiro de 1999). "A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins". The Journal of Biological Chemistry274 (6): 3700–4. PMID9920921. doi:10.1074/jbc.274.6.3700.
Zhao Y, Goto K, Saitoh M, Yanase T, Nomura M, Okabe T, Takayanagi R, Nawata H (agosto de 2002). "Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. Identification of the p102 U5 small nuclear ribonucleoprotein particle-binding protein as a coactivator for the receptor". The Journal of Biological Chemistry277 (33): 30031–9. PMID12039962. doi:10.1074/jbc.M203811200.
Lin HK, Hu YC, Lee DK, Chang C (outubro de 2004). "Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells". Molecular Endocrinology18 (10): 2409–23. PMID15205473. doi:10.1210/me.2004-0117.
Rao MA, Cheng H, Quayle AN, Nishitani H, Nelson CC, Rennie PS (decembro de 2002). "RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor". The Journal of Biological Chemistry277 (50): 48020–7. PMID12361945. doi:10.1074/jbc.M209741200.
Beitel LK, Elhaji YA, Lumbroso R, Wing SS, Panet-Raymond V, Gottlieb B, Pinsky L, Trifiro MA (agosto de 2002). "Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity". Journal of Molecular Endocrinology29 (1): 41–60. PMID12200228. doi:10.1677/jme.0.0290041.
Lu J, Danielsen M (novembro de 1998). "Differential regulation of androgen and glucocorticoid receptors by retinoblastoma protein". The Journal of Biological Chemistry273 (47): 31528–33. PMID9813067. doi:10.1074/jbc.273.47.31528.
Yeh S, Miyamoto H, Nishimura K, Kang H, Ludlow J, Hsiao P, Wang C, Su C, Chang C (xullo de 1998). "Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells". Biochemical and Biophysical Research Communications248 (2): 361–7. PMID9675141. doi:10.1006/bbrc.1998.8974.
Miyamoto H, Rahman M, Takatera H, Kang HY, Yeh S, Chang HC, Nishimura K, Fujimoto N, Chang C (febreiro de 2002). "A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth". The Journal of Biological Chemistry277 (7): 4609–17. PMID11673464. doi:10.1074/jbc.M108312200.
Kang HY, Yeh S, Fujimoto N, Chang C (marzo de 1999). "Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor". The Journal of Biological Chemistry274 (13): 8570–6. PMID10085091. doi:10.1074/jbc.274.13.8570.
Poukka H, Aarnisalo P, Santti H, Jänne OA, Palvimo JJ (xaneiro de 2000). "Coregulator small nuclear RING finger protein (SNURF) enhances Sp1- and steroid receptor-mediated transcription by different mechanisms". The Journal of Biological Chemistry275 (1): 571–9. PMID10617653. doi:10.1074/jbc.275.1.571.
Liu Y, Kim BO, Kao C, Jung C, Dalton JT, He JJ (maio de 2004). "Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activation". The Journal of Biological Chemistry279 (21): 21766–73. PMID15031286. doi:10.1074/jbc.M314321200.
Chipuk JE, Cornelius SC, Pultz NJ, Jorgensen JS, Bonham MJ, Kim SJ, Danielpour D (xaneiro de 2002). "The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3". The Journal of Biological Chemistry277 (2): 1240–8. PMID11707452. doi:10.1074/jbc.M108855200.
Kang HY, Huang KE, Chang SY, Ma WL, Lin WJ, Chang C (novembro de 2002). "Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4". The Journal of Biological Chemistry277 (46): 43749–56. PMID12226080. doi:10.1074/jbc.M205603200.
Gobinet J, Auzou G, Nicolas JC, Sultan C, Jalaguier S (decembro de 2001). "Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP". Biochemistry40 (50): 15369–77. PMID11735420. doi:10.1021/bi011384o.
Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M (outubro de 2004). "Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence". Cancer Research64 (19): 7156–68. PMID15466214. doi:10.1158/0008-5472.CAN-04-1121.
Powell SM, Christiaens V, Voulgaraki D, Waxman J, Claessens F, Bevan CL (marzo de 2004). "Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate". Endocrine-Related Cancer11 (1): 117–30. PMID15027889. doi:10.1677/erc.0.0110117.
Yuan X, Lu ML, Li T, Balk SP (decembro de 2001). "SRY interacts with and negatively regulates androgen receptor transcriptional activity". The Journal of Biological Chemistry276 (49): 46647–54. PMID11585838. doi:10.1074/jbc.M108404200.
Matsuda T, Junicho A, Yamamoto T, Kishi H, Korkmaz K, Saatcioglu F, Fuse H, Muraguchi A (abril de 2001). "Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells". Biochemical and Biophysical Research Communications283 (1): 179–87. PMID11322786. doi:10.1006/bbrc.2001.4758.
Ueda T, Bruchovsky N, Sadar MD (marzo de 2002). "Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways". The Journal of Biological Chemistry277 (9): 7076–85. PMID11751884. doi:10.1074/jbc.M108255200.
Mu X, Chang C (outubro de 2003). "TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3". The Prostate57 (2): 129–33. PMID12949936. doi:10.1002/pros.10282.
Wang X, Yang Y, Guo X, Sampson ER, Hsu CL, Tsai MY, Yeh S, Wu G, Guo Y, Chang C (maio de 2002). "Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator". The Journal of Biological Chemistry277 (18): 15426–31. PMID11856738. doi:10.1074/jbc.M111218200.
Hsiao PW, Chang C (agosto de 1999). "Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells". The Journal of Biological Chemistry274 (32): 22373–9. PMID10428808. doi:10.1074/jbc.274.32.22373.
Miyajima N, Maruyama S, Bohgaki M, Kano S, Shigemura M, Shinohara N, Nonomura K, Hatakeyama S (maio de 2008). "TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells". Cancer Research68 (9): 3486–94. PMID18451177. doi:10.1158/0008-5472.CAN-07-6059.
Poukka H, Aarnisalo P, Karvonen U, Palvimo JJ, Jänne OA (xullo de 1999). "Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription". The Journal of Biological Chemistry274 (27): 19441–6. PMID10383460. doi:10.1074/jbc.274.27.19441.
Cheng S, Brzostek S, Lee SR, Hollenberg AN, Balk SP (xullo de 2002). "Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor". Molecular Endocrinology16 (7): 1492–501. PMID12089345. doi:10.1210/mend.16.7.0870.
Hodgson MC, Astapova I, Cheng S, Lee LJ, Verhoeven MC, Choi E, Balk SP, Hollenberg AN (febreiro de 2005). "The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists". The Journal of Biological Chemistry280 (8): 6511–9. PMID15598662. doi:10.1074/jbc.M408972200.
Bonaccorsi L, Muratori M, Carloni V, Marchiani S, Formigli L, Forti G, Baldi E (agosto de 2004). "The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells". Steroids69 (8–9): 549–52. PMID15288768. doi:10.1016/j.steroids.2004.05.011. hdl:2158/395763.
Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS (xuño de 1995). "Androgen receptor defects: historical, clinical, and molecular perspectives". Endocrine Reviews16 (3): 271–321. PMID7671849. doi:10.1210/edrv-16-3-271.
Gottlieb B, Lombroso R, Beitel LK, Trifiro MA (xaneiro de 2005). "Molecular pathology of the androgen receptor in male (in)fertility". Reproductive Biomedicine Online10 (1): 42–8. PMID15705293. doi:10.1016/S1472-6483(10)60802-4.
Choong CS, Wilson EM (decembro de 1998). "Trinucleotide repeats in the human androgen receptor: a molecular basis for disease". Journal of Molecular Endocrinology21 (3): 235–57. PMID9845666. doi:10.1677/jme.0.0210235.
Meehan KL, Sadar MD (maio de 2003). "Androgens and androgen receptor in prostate and ovarian malignancies". Frontiers in Bioscience8 (1–3): d780–800. PMID12700055. doi:10.2741/1063.
Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL, Wilson EM, McDonnell DP, Cidlowski JA (decembro de 2006). "International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors". Pharmacological Reviews58 (4): 782–97. PMID17132855. doi:10.1124/pr.58.4.9.
Bardin CW, Brown T, Isomaa VV, Jänne OA (1983). "Progestins can mimic, inhibit and potentiate the actions of androgens". Pharmacology & Therapeutics23 (3): 443–59. PMID6371845. doi:10.1016/0163-7258(83)90023-2.
Mooradian AD, Morley JE, Korenman SG (febreiro de 1987). "Biological actions of androgens". Endocrine Reviews8 (1): 1–28. PMID3549275. doi:10.1210/edrv-8-1-1.
Heinlein CA, Chang C (outubro de 2002). "The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions". Molecular Endocrinology16 (10): 2181–7. PMID12351684. doi:10.1210/me.2002-0070.
Davison SL, Bell R (abril de 2006). "Androgen physiology". Seminars in Reproductive Medicine24 (2): 71–7. PMID16633980. doi:10.1055/s-2006-939565.
Frank GR (setembro de 2003). "Role of estrogen and androgen in pubertal skeletal physiology". Medical and Pediatric Oncology41 (3): 217–21. PMID12868122. doi:10.1002/mpo.10340.
Walters KA, Simanainen U, Handelsman DJ (marzo de 2010). "Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models". Human Reproduction Update16 (5): 543–58. PMID20231167. doi:10.1093/humupd/dmq003.
Sinnesael M, Claessens F, Laurent M, Dubois V, Boonen S, Deboel L, Vanderschueren D (decembro de 2012). "Androgen receptor (AR) in osteocytes is important for the maintenance of male skeletal integrity: evidence from targeted AR disruption in mouse osteocytes". Journal of Bone and Mineral Research27 (12): 2535–43. PMID22836391. doi:10.1002/jbmr.1713.
Galani A, Kitsiou-Tzeli S, Sofokleous C, Kanavakis E, Kalpini-Mavrou A (2008). "Androgen insensitivity syndrome: clinical features and molecular defects". Hormones (Athens). 7 (3): 217–29. doi:10.14310/horm.2002.1201. PMID 18694860 .
Heemers HV, Tindall DJ (decembro de 2007). "Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex". Endocrine Reviews28 (7): 778–808. PMID17940184. doi:10.1210/er.2007-0019.
Pandini G, Mineo R, Frasca F, Roberts CT, Marcelli M, Vigneri R, Belfiore A (marzo de 2005). "Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells". Cancer Research65 (5): 1849–57. PMID15753383. doi:10.1158/0008-5472.CAN-04-1837.
Vlahopoulos S, Zimmer WE, Jenster G, Belaguli NS, Balk SP, Brinkmann AO, Lanz RB, Zoumpourlis VC, Schwartz RJ (marzo de 2005). "Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic gene". The Journal of Biological Chemistry280 (9): 7786–92. PMID15623502. doi:10.1074/jbc.M413992200.
Fu M, Wang C, Reutens AT, Wang J, Angeletti RH, Siconolfi-Baez L, Ogryzko V, Avantaggiati ML, Pestell RG (xullo de 2000). "p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation". The Journal of Biological Chemistry275 (27): 20853–60. PMID10779504. doi:10.1074/jbc.M000660200.
Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R (marzo de 2006). "Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells". Oncogene25 (14): 2011–21. PMID16434977. doi:10.1038/sj.onc.1209231.
Fu M, Rao M, Wu K, Wang C, Zhang X, Hessien M, Yeung YG, Gioeli D, Weber MJ, Pestell RG (xullo de 2004). "The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity". The Journal of Biological Chemistry279 (28): 29436–49. PMID15123687. doi:10.1074/jbc.M313466200.
Trapman J, Klaassen P, Kuiper GG, van der Korput JA, Faber PW, van Rooij HC, Geurts van Kessel A, Voorhorst MM, Mulder E, Brinkmann AO (maio de 1988). "Cloning, structure and expression of a cDNA encoding the human androgen receptor". Biochemical and Biophysical Research Communications153 (1): 241–8. PMID3377788. doi:10.1016/S0006-291X(88)81214-2.
Rajender S, Singh L, Thangaraj K (marzo de 2007). "Phenotypic heterogeneity of mutations in androgen receptor gene". Asian Journal of Andrology9 (2): 147–79. PMID17334586. doi:10.1111/j.1745-7262.2007.00250.x.
Gregory CW, He B, Wilson EM (decembro de 2001). "The putative androgen receptor-A form results from in vitro proteolysis". Journal of Molecular Endocrinology27 (3): 309–19. PMID11719283. doi:10.1677/jme.0.0270309.
Brinkmann AO, Klaasen P, Kuiper GG, van der Korput JA, Bolt J, de Boer W, Smit A, Faber PW, van Rooij HC, Geurts van Kessel A (1989). "Structure and function of the androgen receptor". Urological Research17 (2): 87–93. PMID2734982. doi:10.1007/BF00262026.
Langley E, Zhou ZX, Wilson EM (decembro de 1995). "Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer". The Journal of Biological Chemistry270 (50): 29983–90. PMID8530400. doi:10.1074/jbc.270.50.29983.
Berrevoets CA, Doesburg P, Steketee K, Trapman J, Brinkmann AO (agosto de 1998). "Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2)". Molecular Endocrinology12 (8): 1172–83. PMID9717843. doi:10.1210/me.12.8.1172.
Dubbink HJ, Hersmus R, Verma CS, van der Korput HA, Berrevoets CA, van Tol J, Ziel-van der Made AC, Brinkmann AO, Pike AC, Trapman J (setembro de 2004). "Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor". Molecular Endocrinology18 (9): 2132–50. PMID15178743. doi:10.1210/me.2003-0375.
Saporita AJ, Zhang Q, Navai N, Dincer Z, Hahn J, Cai X, Wang Z (outubro de 2003). "Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor". The Journal of Biological Chemistry278 (43): 41998–2005. PMID12923188. doi:10.1074/jbc.M302460200.
Heinlein CA, Chang C (abril de 2002). "Androgen receptor (AR) coregulators: an overview". Endocrine Reviews23 (2): 175–200. PMID11943742. doi:10.1210/edrv.23.2.0460.
Ayub M, Levell MJ (agosto de 1989). "The effect of ketoconazole related imidazole drugs and antiandrogens on [3H] R 1881 binding to the prostatic androgen receptor and [3H]5 alpha-dihydrotestosterone and [3H]cortisol binding to plasma proteins". J. Steroid Biochem.33 (2): 251–5. PMID2788775. doi:10.1016/0022-4731(89)90301-4.
Helsen C, Van den Broeck T, Voet A, Prekovic S, Van Poppel H, Joniau S, Claessens F (agosto de 2014). "Androgen receptor antagonists for prostate cancer therapy". Endocrine-Related Cancer21 (4): T105–18. PMID24639562. doi:10.1530/ERC-13-0545.
Knee DA, Froesch BA, Nuber U, Takayama S, Reed JC (abril de 2001). "Structure-function analysis of Bag1 proteins. Effects on androgen receptor transcriptional activity". The Journal of Biological Chemistry276 (16): 12718–24. PMID11278763. doi:10.1074/jbc.M010841200.
Froesch BA, Takayama S, Reed JC (May 1998). "BAG-1L protein enhances androgen receptor function". The Journal of Biological Chemistry273 (19): 11660–6. PMID9565586. doi:10.1074/jbc.273.19.11660.
Song LN, Coghlan M, Gelmann EP (xaneiro de 2004). "Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor". Molecular Endocrinology18 (1): 70–85. PMID14593076. doi:10.1210/me.2003-0189.
Masiello D, Chen SY, Xu Y, Verhoeven MC, Choi E, Hollenberg AN, Balk SP (outubro de 2004). "Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells". Molecular Endocrinology18 (10): 2388–401. PMID15256534. doi:10.1210/me.2003-0436.
Yang F, Li X, Sharma M, Sasaki CY, Longo DL, Lim B, Sun Z (marzo de 2002). "Linking beta-catenin to androgen-signaling pathway". The Journal of Biological Chemistry277 (13): 11336–44. PMID11792709. doi:10.1074/jbc.M111962200.
Amir AL, Barua M, McKnight NC, Cheng S, Yuan X, Balk SP (agosto de 2003). "A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4". The Journal of Biological Chemistry278 (33): 30828–34. PMID12799378. doi:10.1074/jbc.M301208200.
Mulholland DJ, Read JT, Rennie PS, Cox ME, Nelson CC (agosto de 2003). "Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis". Oncogene22 (36): 5602–13. PMID12944908. doi:10.1038/sj.onc.1206802.
Pawlowski JE, Ertel JR, Allen MP, Xu M, Butler C, Wilson EM, Wierman ME (xuño de 2002). "Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells". The Journal of Biological Chemistry277 (23): 20702–10. PMID11916967. doi:10.1074/jbc.M200545200.
Park JJ, Irvine RA, Buchanan G, Koh SS, Park JM, Tilley WD, Stallcup MR, Press MF, Coetzee GA (novembro de 2000). "Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor". Cancer Research60 (21): 5946–9. PMID11085509.
Sato N, Sadar MD, Bruchovsky N, Saatcioglu F, Rennie PS, Sato S, Lange PH, Gleave ME (xullo de 1997). "Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP". The Journal of Biological Chemistry272 (28): 17485–94. PMID9211894. doi:10.1074/jbc.272.28.17485.
Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP (abril de 2001). "Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation". The Journal of Biological Chemistry276 (16): 13442–51. PMID11278309. doi:10.1074/jbc.M006598200.
Lee DK, Duan HO, Chang C (marzo de 2001). "Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation". The Journal of Biological Chemistry276 (13): 9978–84. PMID11266437. doi:10.1074/jbc.M002285200.
Beauchemin AM, Gottlieb B, Beitel LK, Elhaji YA, Pinsky L, Trifiro MA (2001). "Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy". Brain Research Bulletin56 (3–4): 285–97. PMID11719263. doi:10.1016/S0361-9230(01)00583-4.
Kim J, Jia L, Stallcup MR, Coetzee GA (febreiro de 2005). "The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus". Journal of Molecular Endocrinology34 (1): 107–18. PMID15691881. doi:10.1677/jme.1.01701.
Frønsdal K, Engedal N, Slagsvold T, Saatcioglu F (novembro de 1998). "CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1". The Journal of Biological Chemistry273 (48): 31853–9. PMID9822653. doi:10.1074/jbc.273.48.31853.
Ishitani K, Yoshida T, Kitagawa H, Ohta H, Nozawa S, Kato S (xullo de 2003). "p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor". Biochemical and Biophysical Research Communications306 (3): 660–5. PMID12810069. doi:10.1016/S0006-291X(03)01021-0.
Reutens AT, Fu M, Wang C, Albanese C, McPhaul MJ, Sun Z, Balk SP, Jänne OA, Palvimo JJ, Pestell RG (maio de 2001). "Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner". Molecular Endocrinology15 (5): 797–811. PMID11328859. doi:10.1210/mend.15.5.0641.
Petre-Draviam CE, Williams EB, Burd CJ, Gladden A, Moghadam H, Meller J, Diehl JA, Knudsen KE (xaneiro de 2005). "A central domain of cyclin D1 mediates nuclear receptor corepressor activity". Oncogene24 (3): 431–44. PMID15558026. doi:10.1038/sj.onc.1208200.
Knudsen KE, Cavenee WK, Arden KC (maio de 1999). "D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability". Cancer Research59 (10): 2297–301. PMID10344732.
Lee DK, Duan HO, Chang C (marzo de 2000). "From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator". The Journal of Biological Chemistry275 (13): 9308–13. PMID10734072. doi:10.1074/jbc.275.13.9308.
Niki T, Takahashi-Niki K, Taira T, Iguchi-Ariga SM, Ariga H (febreiro de 2003). "DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex". Molecular Cancer Research1 (4): 247–61. PMID12612053.
Bonaccorsi L, Muratori M, Carloni V, Marchiani S, Formigli L, Forti G, Baldi E (agosto de 2004). "The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells". Steroids69 (8–9): 549–52. PMID15288768. doi:10.1016/j.steroids.2004.05.011. hdl:2158/395763.
Koshy B, Matilla T, Burright EN, Merry DE, Fischbeck KH, Orr HT, Zoghbi HY (setembro de 1996). "Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase". Human Molecular Genetics5 (9): 1311–8. PMID8872471. doi:10.1093/hmg/5.9.1311.
Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, Yeh S, Miyamoto H, Shin M, Aozasa K, Okuyama A, Chang C (agosto de 2003). "Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator". Cancer Research63 (16): 4888–94. PMID12941811.
Rigas AC, Ozanne DM, Neal DE, Robson CN (novembro de 2003). "The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathway". The Journal of Biological Chemistry278 (46): 46087–93. PMID12958311. doi:10.1074/jbc.M306219200.
Wang L, Lin HK, Hu YC, Xie S, Yang L, Chang C (xullo de 2004). "Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells". The Journal of Biological Chemistry279 (31): 32444–52. PMID15178691. doi:10.1074/jbc.M313963200.
Gaughan L, Logan IR, Cook S, Neal DE, Robson CN (xullo de 2002). "Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor". The Journal of Biological Chemistry277 (29): 25904–13. PMID11994312. doi:10.1074/jbc.M203423200.
Veldscholte J, Berrevoets CA, Brinkmann AO, Grootegoed JA, Mulder E (marzo de 1992). "Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation". Biochemistry31 (8): 2393–9. PMID1540595. doi:10.1021/bi00123a026.
Wang Q, Sharma D, Ren Y, Fondell JD (novembro de 2002). "A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression". The Journal of Biological Chemistry277 (45): 42852–8. PMID12218053. doi:10.1074/jbc.M206061200.
Sharma M, Zarnegar M, Li X, Lim B, Sun Z (novembro de 2000). "Androgen receptor interacts with a novel MYST protein, HBO1". The Journal of Biological Chemistry275 (45): 35200–8. PMID10930412. doi:10.1074/jbc.M004838200.
Ueda T, Mawji NR, Bruchovsky N, Sadar MD (outubro de 2002). "Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells". The Journal of Biological Chemistry277 (41): 38087–94. PMID12163482. doi:10.1074/jbc.M203313200.
Wang Q, Udayakumar TS, Vasaitis TS, Brodie AM, Fondell JD (abril de 2004). "Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells". The Journal of Biological Chemistry279 (17): 17319–28. PMID14966121. doi:10.1074/jbc.M400970200.
Tan JA, Hall SH, Petrusz P, French FS (setembro de 2000). "Thyroid receptor activator molecule, TRAM-1, is an androgen receptor coactivator". Endocrinology141 (9): 3440–50. PMID10965917. doi:10.1210/endo.141.9.7680.
He B, Minges JT, Lee LW, Wilson EM (marzo de 2002). "The FXXLF motif mediates androgen receptor-specific interactions with coregulators". The Journal of Biological Chemistry277 (12): 10226–35. PMID11779876. doi:10.1074/jbc.M111975200.
Alen P, Claessens F, Schoenmakers E, Swinnen JV, Verhoeven G, Rombauts W, Peeters B (xaneiro de 1999). "Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform". Molecular Endocrinology13 (1): 117–28. PMID9892017. doi:10.1210/mend.13.1.0214.
Zhou ZX, He B, Hall SH, Wilson EM, French FS (febreiro de 2002). "Domain interactions between coregulator ARA(70) and the androgen receptor (AR)". Molecular Endocrinology16 (2): 287–300. PMID11818501. doi:10.1210/mend.16.2.0765.
Gao T, Brantley K, Bolu E, McPhaul MJ (outubro de 1999). "RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays". Molecular Endocrinology13 (10): 1645–56. PMID10517667. doi:10.1210/mend.13.10.0352.
Goo YH, Na SY, Zhang H, Xu J, Hong S, Cheong J, Lee SK, Lee JW (febreiro de 2004). "Interactions between activating signal cointegrator-2 and the tumor suppressor retinoblastoma in androgen receptor transactivation". The Journal of Biological Chemistry279 (8): 7131–5. PMID14645241. doi:10.1074/jbc.M312563200.
Liao G, Chen LY, Zhang A, Godavarthy A, Xia F, Ghosh JC, Li H, Chen JD (febreiro de 2003). "Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT". The Journal of Biological Chemistry278 (7): 5052–61. PMID12441355. doi:10.1074/jbc.M206374200.
Dotzlaw H, Moehren U, Mink S, Cato AC, Iñiguez Lluhí JA, Baniahmad A (abril de 2002). "The amino terminus of the human AR is target for corepressor action and antihormone agonism". Molecular Endocrinology16 (4): 661–73. PMID11923464. doi:10.1210/me.16.4.661.
Fu M, Wang C, Reutens AT, Wang J, Angeletti RH, Siconolfi-Baez L, et al. (xullo 2000). "p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation". The Journal of Biological Chemistry275 (27): 20853–60. PMID10779504. doi:10.1074/jbc.M000660200.
Zhang Y, Fondell JD, Wang Q, Xia X, Cheng A, Lu ML, Hamburger AW (agosto de 2002). "Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1". Oncogene21 (36): 5609–18. PMID12165860. doi:10.1038/sj.onc.1205638.
Yang F, Li X, Sharma M, Zarnegar M, Lim B, Sun Z (maio de 2001). "Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6". The Journal of Biological Chemistry276 (18): 15345–53. PMID11278661. doi:10.1074/jbc.M010311200.
Lee SR, Ramos SM, Ko A, Masiello D, Swanson KD, Lu ML, Balk SP (xaneiro de 2002). "AR and ER interaction with a p21-activated kinase (PAK6)". Molecular Endocrinology16 (1): 85–99. PMID11773441. doi:10.1210/mend.16.1.0753.
Pero R, Lembo F, Palmieri EA, Vitiello C, Fedele M, Fusco A, Bruni CB, Chiariotti L (febreiro de 2002). "PATZ attenuates the RNF4-mediated enhancement of androgen receptor-dependent transcription". The Journal of Biological Chemistry277 (5): 3280–5. PMID11719514. doi:10.1074/jbc.M109491200.
Kotaja N, Aittomäki S, Silvennoinen O, Palvimo JJ, Jänne OA (decembro de 2000). "ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation". Molecular Endocrinology14 (12): 1986–2000. PMID11117529. doi:10.1210/mend.14.12.0569.
Moilanen AM, Karvonen U, Poukka H, Yan W, Toppari J, Jänne OA, Palvimo JJ (febreiro de 1999). "A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins". The Journal of Biological Chemistry274 (6): 3700–4. PMID9920921. doi:10.1074/jbc.274.6.3700.
Zhao Y, Goto K, Saitoh M, Yanase T, Nomura M, Okabe T, Takayanagi R, Nawata H (agosto de 2002). "Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. Identification of the p102 U5 small nuclear ribonucleoprotein particle-binding protein as a coactivator for the receptor". The Journal of Biological Chemistry277 (33): 30031–9. PMID12039962. doi:10.1074/jbc.M203811200.
Lin HK, Hu YC, Lee DK, Chang C (outubro de 2004). "Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells". Molecular Endocrinology18 (10): 2409–23. PMID15205473. doi:10.1210/me.2004-0117.
Rao MA, Cheng H, Quayle AN, Nishitani H, Nelson CC, Rennie PS (decembro de 2002). "RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor". The Journal of Biological Chemistry277 (50): 48020–7. PMID12361945. doi:10.1074/jbc.M209741200.
Beitel LK, Elhaji YA, Lumbroso R, Wing SS, Panet-Raymond V, Gottlieb B, Pinsky L, Trifiro MA (agosto de 2002). "Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity". Journal of Molecular Endocrinology29 (1): 41–60. PMID12200228. doi:10.1677/jme.0.0290041.
Lu J, Danielsen M (novembro de 1998). "Differential regulation of androgen and glucocorticoid receptors by retinoblastoma protein". The Journal of Biological Chemistry273 (47): 31528–33. PMID9813067. doi:10.1074/jbc.273.47.31528.
Yeh S, Miyamoto H, Nishimura K, Kang H, Ludlow J, Hsiao P, Wang C, Su C, Chang C (xullo de 1998). "Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells". Biochemical and Biophysical Research Communications248 (2): 361–7. PMID9675141. doi:10.1006/bbrc.1998.8974.
Miyamoto H, Rahman M, Takatera H, Kang HY, Yeh S, Chang HC, Nishimura K, Fujimoto N, Chang C (febreiro de 2002). "A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth". The Journal of Biological Chemistry277 (7): 4609–17. PMID11673464. doi:10.1074/jbc.M108312200.
Kang HY, Yeh S, Fujimoto N, Chang C (marzo de 1999). "Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor". The Journal of Biological Chemistry274 (13): 8570–6. PMID10085091. doi:10.1074/jbc.274.13.8570.
Poukka H, Aarnisalo P, Santti H, Jänne OA, Palvimo JJ (xaneiro de 2000). "Coregulator small nuclear RING finger protein (SNURF) enhances Sp1- and steroid receptor-mediated transcription by different mechanisms". The Journal of Biological Chemistry275 (1): 571–9. PMID10617653. doi:10.1074/jbc.275.1.571.
Liu Y, Kim BO, Kao C, Jung C, Dalton JT, He JJ (maio de 2004). "Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activation". The Journal of Biological Chemistry279 (21): 21766–73. PMID15031286. doi:10.1074/jbc.M314321200.
Chipuk JE, Cornelius SC, Pultz NJ, Jorgensen JS, Bonham MJ, Kim SJ, Danielpour D (xaneiro de 2002). "The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3". The Journal of Biological Chemistry277 (2): 1240–8. PMID11707452. doi:10.1074/jbc.M108855200.
Hayes SA, Zarnegar M, Sharma M, Yang F, Peehl DM, ten Dijke P, Sun Z (marzo de 2001). "SMAD3 represses androgen receptor-mediated transcription". Cancer Research61 (5): 2112–8. PMID11280774.
Kang HY, Huang KE, Chang SY, Ma WL, Lin WJ, Chang C (novembro de 2002). "Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4". The Journal of Biological Chemistry277 (46): 43749–56. PMID12226080. doi:10.1074/jbc.M205603200.
Gobinet J, Auzou G, Nicolas JC, Sultan C, Jalaguier S (decembro de 2001). "Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP". Biochemistry40 (50): 15369–77. PMID11735420. doi:10.1021/bi011384o.
Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M (outubro de 2004). "Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence". Cancer Research64 (19): 7156–68. PMID15466214. doi:10.1158/0008-5472.CAN-04-1121.
Powell SM, Christiaens V, Voulgaraki D, Waxman J, Claessens F, Bevan CL (marzo de 2004). "Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate". Endocrine-Related Cancer11 (1): 117–30. PMID15027889. doi:10.1677/erc.0.0110117.
Yuan X, Lu ML, Li T, Balk SP (decembro de 2001). "SRY interacts with and negatively regulates androgen receptor transcriptional activity". The Journal of Biological Chemistry276 (49): 46647–54. PMID11585838. doi:10.1074/jbc.M108404200.
Matsuda T, Junicho A, Yamamoto T, Kishi H, Korkmaz K, Saatcioglu F, Fuse H, Muraguchi A (abril de 2001). "Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells". Biochemical and Biophysical Research Communications283 (1): 179–87. PMID11322786. doi:10.1006/bbrc.2001.4758.
Ueda T, Bruchovsky N, Sadar MD (marzo de 2002). "Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways". The Journal of Biological Chemistry277 (9): 7076–85. PMID11751884. doi:10.1074/jbc.M108255200.
Mu X, Chang C (outubro de 2003). "TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3". The Prostate57 (2): 129–33. PMID12949936. doi:10.1002/pros.10282.
Wang X, Yang Y, Guo X, Sampson ER, Hsu CL, Tsai MY, Yeh S, Wu G, Guo Y, Chang C (maio de 2002). "Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator". The Journal of Biological Chemistry277 (18): 15426–31. PMID11856738. doi:10.1074/jbc.M111218200.
Hsiao PW, Chang C (agosto de 1999). "Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells". The Journal of Biological Chemistry274 (32): 22373–9. PMID10428808. doi:10.1074/jbc.274.32.22373.
Miyajima N, Maruyama S, Bohgaki M, Kano S, Shigemura M, Shinohara N, Nonomura K, Hatakeyama S (maio de 2008). "TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells". Cancer Research68 (9): 3486–94. PMID18451177. doi:10.1158/0008-5472.CAN-07-6059.
Poukka H, Aarnisalo P, Karvonen U, Palvimo JJ, Jänne OA (xullo de 1999). "Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription". The Journal of Biological Chemistry274 (27): 19441–6. PMID10383460. doi:10.1074/jbc.274.27.19441.
Cheng S, Brzostek S, Lee SR, Hollenberg AN, Balk SP (xullo de 2002). "Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor". Molecular Endocrinology16 (7): 1492–501. PMID12089345. doi:10.1210/mend.16.7.0870.
Hodgson MC, Astapova I, Cheng S, Lee LJ, Verhoeven MC, Choi E, Balk SP, Hollenberg AN (febreiro de 2005). "The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists". The Journal of Biological Chemistry280 (8): 6511–9. PMID15598662. doi:10.1074/jbc.M408972200.